These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

450 related items for PubMed ID: 27112236

  • 1. Cacna1g is a genetic modifier of epilepsy caused by mutation of voltage-gated sodium channel Scn2a.
    Calhoun JD, Hawkins NA, Zachwieja NJ, Kearney JA.
    Epilepsia; 2016 Jun; 57(6):e103-7. PubMed ID: 27112236
    [Abstract] [Full Text] [Related]

  • 2. Hlf is a genetic modifier of epilepsy caused by voltage-gated sodium channel mutations.
    Hawkins NA, Kearney JA.
    Epilepsy Res; 2016 Jan; 119():20-3. PubMed ID: 26656780
    [Abstract] [Full Text] [Related]

  • 3. Cacna1g is a genetic modifier of epilepsy in a mouse model of Dravet syndrome.
    Calhoun JD, Hawkins NA, Zachwieja NJ, Kearney JA.
    Epilepsia; 2017 Aug; 58(8):e111-e115. PubMed ID: 28556246
    [Abstract] [Full Text] [Related]

  • 4. CaMKII modulates sodium current in neurons from epileptic Scn2a mutant mice.
    Thompson CH, Hawkins NA, Kearney JA, George AL.
    Proc Natl Acad Sci U S A; 2017 Feb 14; 114(7):1696-1701. PubMed ID: 28137877
    [Abstract] [Full Text] [Related]

  • 5. Confirmation of an epilepsy modifier locus on mouse chromosome 11 and candidate gene analysis by RNA-Seq.
    Hawkins NA, Kearney JA.
    Genes Brain Behav; 2012 Jun 14; 11(4):452-60. PubMed ID: 22471526
    [Abstract] [Full Text] [Related]

  • 6. Fine mapping of an epilepsy modifier gene on mouse Chromosome 19.
    Bergren SK, Rutter ED, Kearney JA.
    Mamm Genome; 2009 Jun 14; 20(6):359-66. PubMed ID: 19513789
    [Abstract] [Full Text] [Related]

  • 7. Severe epilepsy resulting from genetic interaction between Scn2a and Kcnq2.
    Kearney JA, Yang Y, Beyer B, Bergren SK, Claes L, Dejonghe P, Frankel WN.
    Hum Mol Genet; 2006 Mar 15; 15(6):1043-8. PubMed ID: 16464983
    [Abstract] [Full Text] [Related]

  • 8. Neuronal voltage-gated ion channels are genetic modifiers of generalized epilepsy with febrile seizures plus.
    Hawkins NA, Martin MS, Frankel WN, Kearney JA, Escayg A.
    Neurobiol Dis; 2011 Mar 15; 41(3):655-60. PubMed ID: 21156207
    [Abstract] [Full Text] [Related]

  • 9. Genetic modifiers affecting severity of epilepsy caused by mutation of sodium channel Scn2a.
    Bergren SK, Chen S, Galecki A, Kearney JA.
    Mamm Genome; 2005 Sep 15; 16(9):683-90. PubMed ID: 16245025
    [Abstract] [Full Text] [Related]

  • 10. Fine Mapping of a Dravet Syndrome Modifier Locus on Mouse Chromosome 5 and Candidate Gene Analysis by RNA-Seq.
    Hawkins NA, Zachwieja NJ, Miller AR, Anderson LL, Kearney JA.
    PLoS Genet; 2016 Oct 15; 12(10):e1006398. PubMed ID: 27768696
    [Abstract] [Full Text] [Related]

  • 11. Genetic and phenotypic heterogeneity suggest therapeutic implications in SCN2A-related disorders.
    Wolff M, Johannesen KM, Hedrich UBS, Masnada S, Rubboli G, Gardella E, Lesca G, Ville D, Milh M, Villard L, Afenjar A, Chantot-Bastaraud S, Mignot C, Lardennois C, Nava C, Schwarz N, Gérard M, Perrin L, Doummar D, Auvin S, Miranda MJ, Hempel M, Brilstra E, Knoers N, Verbeek N, van Kempen M, Braun KP, Mancini G, Biskup S, Hörtnagel K, Döcker M, Bast T, Loddenkemper T, Wong-Kisiel L, Baumeister FM, Fazeli W, Striano P, Dilena R, Fontana E, Zara F, Kurlemann G, Klepper J, Thoene JG, Arndt DH, Deconinck N, Schmitt-Mechelke T, Maier O, Muhle H, Wical B, Finetti C, Brückner R, Pietz J, Golla G, Jillella D, Linnet KM, Charles P, Moog U, Õiglane-Shlik E, Mantovani JF, Park K, Deprez M, Lederer D, Mary S, Scalais E, Selim L, Van Coster R, Lagae L, Nikanorova M, Hjalgrim H, Korenke GC, Trivisano M, Specchio N, Ceulemans B, Dorn T, Helbig KL, Hardies K, Stamberger H, de Jonghe P, Weckhuysen S, Lemke JR, Krägeloh-Mann I, Helbig I, Kluger G, Lerche H, Møller RS.
    Brain; 2017 May 01; 140(5):1316-1336. PubMed ID: 28379373
    [Abstract] [Full Text] [Related]

  • 12. Scn2a deletion improves survival and brain-heart dynamics in the Kcna1-null mouse model of sudden unexpected death in epilepsy (SUDEP).
    Mishra V, Karumuri BK, Gautier NM, Liu R, Hutson TN, Vanhoof-Villalba SL, Vlachos I, Iasemidis L, Glasscock E.
    Hum Mol Genet; 2017 Jun 01; 26(11):2091-2103. PubMed ID: 28334922
    [Abstract] [Full Text] [Related]

  • 13. A gain-of-function mutation in the sodium channel gene Scn2a results in seizures and behavioral abnormalities.
    Kearney JA, Plummer NW, Smith MR, Kapur J, Cummins TR, Waxman SG, Goldin AL, Meisler MH.
    Neuroscience; 2001 Jun 01; 102(2):307-17. PubMed ID: 11166117
    [Abstract] [Full Text] [Related]

  • 14. Voltage-gated potassium channel KCNV2 (Kv8.2) contributes to epilepsy susceptibility.
    Jorge BS, Campbell CM, Miller AR, Rutter ED, Gurnett CA, Vanoye CG, George AL, Kearney JA.
    Proc Natl Acad Sci U S A; 2011 Mar 29; 108(13):5443-8. PubMed ID: 21402906
    [Abstract] [Full Text] [Related]

  • 15. Antiepileptic activity of preferential inhibitors of persistent sodium current.
    Anderson LL, Thompson CH, Hawkins NA, Nath RD, Petersohn AA, Rajamani S, Bush WS, Frankel WN, Vanoye CG, Kearney JA, George AL.
    Epilepsia; 2014 Aug 29; 55(8):1274-83. PubMed ID: 24862204
    [Abstract] [Full Text] [Related]

  • 16. Environmental enrichment reduces spontaneous seizures in the Q54 transgenic mouse model of temporal lobe epilepsy.
    Manno I, Macchi F, Caleo M, Bozzi Y.
    Epilepsia; 2011 Sep 29; 52(9):e113-7. PubMed ID: 21762452
    [Abstract] [Full Text] [Related]

  • 17. Confirming an expanded spectrum of SCN2A mutations: a case series.
    Matalon D, Goldberg E, Medne L, Marsh ED.
    Epileptic Disord; 2014 Mar 29; 16(1):13-8. PubMed ID: 24659627
    [Abstract] [Full Text] [Related]

  • 18. Infantile Epileptic Encephalopathy Associated With SCN2A Mutation Responsive to Oral Mexiletine.
    Foster LA, Johnson MR, MacDonald JT, Karachunski PI, Henry TR, Nascene DR, Moran BP, Raymond GV.
    Pediatr Neurol; 2017 Jan 29; 66():108-111. PubMed ID: 27867041
    [Abstract] [Full Text] [Related]

  • 19. Scn2a sodium channel mutation results in hyperexcitability in the hippocampus in vitro.
    Kile KB, Tian N, Durand DM.
    Epilepsia; 2008 Mar 29; 49(3):488-99. PubMed ID: 18031550
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.